• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Illumina (ILMN)

Common Shares
Sell: $134.50|Buy: $136.00|Change: 4.27 (3.27%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Address

5200 Illumina Way
San Diego
CA
USA
92122

Telephone

+1 858 2916421

Website

https://www.illumina.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Illumina Inc Third Quarter Earnings Conference Call for 20262026-10-30T16:30:00
Illumina Inc Third Quarter Earnings Results for 20262026-10-30T00:00:00
Illumina Inc Second Quarter Earnings Conference Call for 20262026-07-31T16:30:00
Illumina Inc Second Quarter Earnings Results for 20262026-07-31T00:00:00
Illumina Inc Annual General Meeting for 20252026-05-21T10:00:00
Illumina Inc First Quarter Earnings Conference Call for 20262026-05-08T16:30:00
Illumina Inc First Quarter Earnings Results for 20262026-05-08T00:00:00
Illumina Inc Annual Report for 20252026-02-12T00:00:00
Illumina Inc Fourth Quarter Earnings Conference Call for 20252026-02-06T16:30:00
Illumina Inc Fourth Quarter Earnings Results for 20252026-02-06T00:00:00
44 Annual J.P. Morgan Healthcare Conference2026-01-13T10:30:00

Previous key dates

NameKey Date
Wolfe Research Healthcare Conference2025-11-19T09:20:00
Illumina Inc Third Quarter Earnings Conference Call for 20252025-10-30T16:30:00
Illumina Inc Third Quarter Earnings Result for 20252025-10-30T00:00:00
Illumina Inc Second Quarter Earnings Conference Call for 20252025-07-31T16:30:00
Illumina Inc Second Quarter Earnings Results for 20252025-07-31T00:00:00
41st Annual Bernstein Strategic Decisions Conference2025-05-28T14:30:00
Illumina Inc Annual General Meeting for 20242025-05-21T10:00:00
Illumina Inc First Quarter Earnings Conference Call for 20252025-05-08T16:30:00
Illumina Inc First Quarter Earnings Result for 20252025-05-08T00:00:00
Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference2025-02-25T11:00:00
Illumina Inc Annual Report for 20242025-02-12T00:00:00
Illumina Inc Fourth Quarter Earnings Conference Call for 20242025-02-06T16:30:00
Illumina Inc Fourth Quarter Earnings Result for 20242025-02-06T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-14T12:20:00
7th Annual Evercore HealthCONx Conference2024-12-03T13:20:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.